The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis

Brain

Volumn 135, Issue 9, 2012, Pages 2865-2874

  Kim, Hyun Jeong ^a   Magranè, Jordi ^a   Starkov, Anatoly A ^a   Manfredi, Giovanni ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

amyotrophic lateral sclerosis; calcium; cyclophilin D; mitochondria; oestrogen; SOD1; transgenic mice

Indexed keywords

CALCIUM ION; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOPHILIN D; ESTRADIOL; GLUTAMIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; FEMALE; GENETIC ABLATION; GENETIC PROCEDURES; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOTONEURON; MOUSE; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; SPINAL CORD;

EID: 84866354854     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws208     Document Type: Article

References (41)

1. Alvarez-Delgado C, Mendoza-Rodriguez CA, Picazo O, Cerbon M. Different expression of alpha and beta mitochondrial estrogen receptors in the aging rat brain: interaction with respiratory complex V. Exp Gerontol 2010; 45: 580-5.
2. Arieli Y, Gursahani H, Eaton MM, Hernandez LA, Schaefer S. Gender modulation of Ca(2 +) uptake in cardiac mitochondria. J Mol Cell Cardiol 2004; 37: 507-13.
3. Batra SC. Effect of some estrogens and progesterone on calcium uptake and calcium release by myometrial mitochondria. Biochem Pharmacol 1973; 22: 803-9.
4. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 1999; 79: 1127-55.
5. Chalmers S, Nicholls DG. The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria. J Biol Chem 2003; 278: 19062-70.
6. Chinopoulos C, Konrad C, Kiss G, Metelkin E, Torocsik B, Zhang SF, et al. Modulation of F0F1-ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels. FEBS J 2011; 278: 1112-25.
7. Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011; 82: 740-6.
8. Chio A, Meineri P, Tribolo A, Schiffer D. Risk factors in motor neuron disease: a case-control study. Neuroepidemiology 1991; 10: 174-84.
9. Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A trans-genic mice. J Neurol Sci 2008; 268: 40-7.
10. Connern CP, Halestrap AP. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem J 1994; 302 (Pt 2): 321-4.
11. Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, et al. Neural mitochondrial Ca2 + capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J Neurochem 2006; 96: 1349-61.
12. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008; 14: 1097-105.
13. Giorgio V, Bisetto E, Soriano ME, Dabbeni-Sala F, Basso E, Petronilli V, et al. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 2009; 284: 33982-8.
14. Groeneveld GJ, Van Muiswinkel FL, Sturkenboom JM, Wokke JH, Bar PR, Van Den Berg LH. Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res 2004; 1021: 128-31.
15. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-5.
16. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118 (Pt 3): 707-19.
17. Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci 2005; 236: 1-7.
18. Horvat A, Petrovic S, Nedeljkovic N, Martinovic JV, Nikezic G. Estradiol affect Na-dependent Ca2+ efflux from synaptosomal mitochondria. Gen Physiol Biophys 2000; 19: 59-71.
19. Igoudjil A, Magrane J, Fischer LR, Kim HJ, Hervias I, Dumont M, et al. In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J Neurosci 2011; 31: 15826-37.
20. Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010; 67: 575-87.
21. Jung C, Higgins CMJ, Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem 2002; 83: 535-45.
22. Kawamata H, Manfredi G. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev 2010; 131: 517-26.
23. Kim HJ, Magrane J. Isolation and culture of neurons and astrocytes from the mouse brain cortex. Methods Mol Biol 2011; 793: 63-75.
24. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003; 53: 804-7.
25. Kruman II, Pedersen WA, Springer JE, Mattson MP. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excito-toxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 1999; 160: 28-39.
26. Lobaton CD, Vay L, Hernandez-Sanmiguel E, Santodomingo J, Moreno A, Montero M, et al. Modulation of mitochondrial Ca(2 +) uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 2005; 145: 862-71.
27. Magrane J, Sahawneh MA, Przedborski S, Estevez AG, Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci 2012; 32: 229-42.
28. Martin LJ, Gertz B, Pan Y, Price AC, Molkentin JD, Chang Q. The mito-chondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp Neurol 2009; 218: 333-46.
29. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 2002; 277: 29626-33.
30. Moro L, Arbini AA, Hsieh JT, Ford J, Simpson ER, Hajibeigi A, et al. Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria. Endocrinology 2010; 151: 1643-52.
31. Novgorodov SA, Gudz TI. Permeability transition pore of the inner mito-chondrial membrane can operate in two open states with different selectivities. J Bioenerg Biomembr 1996; 28: 139-46.
32. Pedrini S, Sau D, Guareschi S, Bogush M, Brown RH Jr, Naniche N, et al. ALS-linked mutant SOD1 damages mitochondria by promoting con-formational changes in Bcl-2. Hum Mol Genet 2010; 19: 2974-86.
33. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
34. Rothstein JD. Excitotoxicity hypothesis. Neurology 1996; 47 (4 Suppl 2): S19-25. discussion S6.
35. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-700.
36. Rudnicki SA. Estrogen replacement therapy in women with amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 126-7.
37. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A 2005; 102: 12005-10.
38. Thomas B, Banerjee R, Starkova NN, Zhang SF, Calingasan NY, Yang L, et al. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's Disease. Antioxid Redox Signal 2012; 16: 855-68.
39. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999; 52: 504-9.
40. Wang X, Dykens JA, Perez E, Liu R, Yang S, Covey DF, et al. Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol 2006; 70: 395-404.
41. Yang SH, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, et al. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A 2004; 101: 4130-5.